Optimization of Ureterolysis During Hysterectomy

February 24, 2018 updated by: Case Comprehensive Cancer Center

Optimization of Parameters for Ureterolysis During Minimally Invasive Hysterectomy; Determining Variation in Ureter Position and Degree of Thermal Spread

The purpose of this study is to improve the safety of surgery to remove a uterus (a hysterectomy) by better understanding where a patient's ureters lie.

Study Overview

Status

Withdrawn

Conditions

Detailed Description

Objectives:

Primary: (While uterus is under tension)

  • To determine the shortest distance from the ureter to the uterine vessels.
  • To determine the distances from the ureter to the gonadal vessels in infundibulo-pelvic (IP) at the pelvic sidewall. This will be defined at the distance from the IP ligament at the level of the pelvic sidewall to the point on the ureter directly below these vessels
  • To determine the distances from the ureter to the gonadal vessels in the infundibulo-pelvic (IP) ligament at the point where the gonadal vessels enter in to the ovary. This will be defined as the distance from where the vessels in the IP enter the ovary to the point on the ureter directly below this.

Secondary

  • To determine thermal spread from the Ligasure, and Harmonic device using H&E and Movat staining.
  • To determine the burst pressure of segments of IP ligament that have undergone Ligasure or Harmonic electrosurgery.

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women undergoing minimally invasive surgery (MIS) hysterectomy with Bilateral Salpingo Oophorectomy (BSO) for either a benign or malignant condition.
  • Performance Status of 0-1
  • Must have the ability to understand and willingness to sign a written informed consent document

Exclusion Criteria:

  • History of radical pelvic surgery.
  • History of stage IV-V uterine prolapse or hysteropexy
  • History of prior ureteral injury or retroperitoneal dissection
  • Known hydronephrosis.
  • Known congenital genitourinary or gynaecologic anomaly
  • Any known obstructing mass along any portion of the pelvic ureter
  • Known American Society for Reproductive Medicine (ASRM) stage III/IV endometriosis (obliteration of the cul-de-sac)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cook Bush DL™ Ureteral Illuminating Catheter
As part of this study an additional tool will be used during the hysterectomy. This tool is called a Cook Bush DL™ Ureteral Illuminating Catheter, which is a lighted ureteral stent. This is a very thin tube that goes into the ureter. A urologist, who is an expert at placing these devices, will insert a stent into each ureter during surgery. The lighted stents will help effectively find the ureters and keep track of them during the surgery. This same procedure is already being done in many other forms of abdominal surgery to help find the ureter. The stents will be removed before the surgery is complete and treatment will not differ in any other way.
This is a very thin tube that goes into a ureter to more effectively find and track the ureter during surgeries
Other Names:
  • ureteral stent

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distance from the ureter to the uterine vessels
Time Frame: Cross-sectional measurement at time of surgery
To determine the shortest distance from the ureter to the uterine vessels to show the variation of ureteral position to the uterine and gonadal vessels during total laparoscopic hysterectomy prior to and following opening the retroperitoneum. Lighted ureteral stents will be placed cystoscopically. This will be done to clearly delineate the ureter and facilitate measuring the ureter to the infundibulopelvic (IP) and ureter to uterine vessel distances.
Cross-sectional measurement at time of surgery
The distance from the ureter to the right gonadal vessel at the pelvic sidewall
Time Frame: Cross-sectional measurement at time of surgery
To determine the average distance from the ureter to the right gonadal vessel in infundibulo-pelvic (IP) at the pelvic sidewall. This is to show the variation of ureteral position to the uterine and gonadal vessels during total laparoscopic hysterectomy prior to and following opening the retroperitoneum. Lighted ureteral stents will be placed cystoscopically. This will be done to clearly delineate the ureter and facilitate measuring the ureter to the infundibulopelvic (IP) and ureter to uterine vessel distances.
Cross-sectional measurement at time of surgery
The distance from the ureter to the left gonadal vessel at the pelvic sidewall
Time Frame: Cross-sectional measurement at time of surgery
To determine the distance from the ureter to the left gonadal vessel in infundibulo-pelvic (IP) at the pelvic sidewall. This is to show the variation of ureteral position to the uterine and gonadal vessels during total laparoscopic hysterectomy prior to and following opening the retroperitoneum. Lighted ureteral stents will be placed cystoscopically. This will be done to clearly delineate the ureter and facilitate measuring the ureter to the infundibulopelvic (IP) and ureter to uterine vessel distances.
Cross-sectional measurement at time of surgery
The distance from the ureter to the right gonadal vessel where the gonadal vessel enter in to the ovary
Time Frame: Cross-sectional measurement at time of surgery
To determine the distance from the ureter to the right gonadal vessel in the infundibulo-pelvic (IP) ligament at the point where the gonadal vessels enter in to the ovary. This is to show the variation of ureteral position to the uterine and gonadal vessels during total laparoscopic hysterectomy prior to and following opening the retroperitoneum. Lighted ureteral stents will be placed cystoscopically. This will be done to clearly delineate the ureter and facilitate measuring the ureter to the infundibulopelvic (IP) and ureter to uterine vessel distances.
Cross-sectional measurement at time of surgery
The distance from the ureter to the left gonadal vessel where the gonadal vessel enter in to the ovary
Time Frame: Cross-sectional measurement at time of surgery
To determine the distance from the ureter to the left gonadal vessel in the infundibulo-pelvic (IP) ligament at the point where the gonadal vessels enter in to the ovary. This is to show the variation of ureteral position to the uterine and gonadal vessels during total laparoscopic hysterectomy prior to and following opening the retroperitoneum. Lighted ureteral stents will be placed cystoscopically. This will be done to clearly delineate the ureter and facilitate measuring the ureter to the infundibulopelvic (IP) and ureter to uterine vessel distances.
Cross-sectional measurement at time of surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To determine the burst pressure of infundibulopelvic (IP) ligament which had Ligasure electrosurgery
Time Frame: Cross-sectional measurement at time of surgery
To determine the burst pressure of segments of IP ligament that have undergone Ligasure electrosurgery. The Ligasure electrosurgery cuts and seals the tissue during surgery. The burst pressure gives a measure of how well the tissue is sealed.
Cross-sectional measurement at time of surgery
To determine the burst pressure of infundibulopelvic ligament which had Harmonic electrosurgery
Time Frame: Cross-sectional measurement at time of surgery
To determine the burst pressure of segments of IP ligament that have undergone Harmonic electrosurgery. The Harmonic electrosurgery cuts and seals the tissue during surgery. The burst pressure gives a measure of how well the tissue is sealed.
Cross-sectional measurement at time of surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
To determine thermal spread from a Ligasure to show the
Time Frame: Cross-sectional measurement immediately after surgery
Thermal spread is the dispersal of heat into surrounding tissue during electrosurgeries, causing damage to the tissue.In order to measure thermal spread, the gonadal vessels will be harvested after the specimen (uterus, tubes, ovaries and cervix) has been removed from the patient
Cross-sectional measurement immediately after surgery
To determine thermal spread from a Harmonic device
Time Frame: Cross-sectional measurement immediately after surgery
Thermal spread is the dispersal of heat into surrounding tissue during electrosurgeries, causing damage to the tissue. In order to measure thermal spread, the gonadal vessels will be harvested after the specimen (uterus, tubes, ovaries and cervix) has been removed from the patient
Cross-sectional measurement immediately after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Robert Debernardo, MD, Cleveland Clinic, Case Comprehensive Cancer Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2018

Primary Completion (Anticipated)

December 1, 2019

Study Completion (Anticipated)

June 1, 2020

Study Registration Dates

First Submitted

April 14, 2017

First Submitted That Met QC Criteria

April 20, 2017

First Posted (Actual)

April 21, 2017

Study Record Updates

Last Update Posted (Actual)

February 27, 2018

Last Update Submitted That Met QC Criteria

February 24, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • CASE11815

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hysterectomy

Clinical Trials on Ureteral Illuminating Catheter

Subscribe